← Back to Clinical Trials
Recruiting NCT04260165

NCT04260165 Proximal Row Carpectomy vs Four-corner Fusion for Osteoarthritis of the Wrist

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04260165
Status Recruiting
Phase —
Sponsor Töölö Hospital
Condition Wrist Osteoarthritis
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2020-10-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Proximal Row CarpectomyFour-corner fusion

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2020-10-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Study purpose is to compare the outcome after proximal row carpectomy (PRC) vs four-corner fusion (FCA) for SLAC/SNAC II-III type osteoarthritis (OA) in a double-blinded randomized controlled study setting. Patients with radiologically and clinically confirmed OA are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo either PRC or FCA. The study will be patient and assessor blinded. Baseline data is collected preoperatively and is followed by a follow-up visits at 2 and 6 weeks, 3, 6, 12 months, and 5, 10 years after the intervention. Unveiling of the allocation is at 12 months post-intervention.

Eligibility Criteria

Inclusion Criteria: * SLAC/SNAC II-III * Age 18 - 75 * Symptom duration \> 3 months * American Society of Anaesthesiologists physical status (ASA) I-II Exclusion Criteria: * Patient eligible for SL reconstruction or scaphoid * Ulnocarpal/pancarpal arthritis * Lunate fossa, proximal lunate arthrosis or both * Age \<18 or \>75 years * Rheumatoid arthritis * Heavy smoking (\> 20 cigarettes per day) * Condition or medication affecting bony healing (eg diabetes mellitus with poor glycemic control, malnutrition, use of per oral corticosteroids) * Alcohol or drug abuse * Neurological condition affecting upper limb function

Contact & Investigator

Central Contact

Samuli Aspinen, MD, PhD

✉ samuli.aspinen@hus.fi

📞 +358406360546

Frequently Asked Questions

Who can join the NCT04260165 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Wrist Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04260165 currently recruiting?

Yes, NCT04260165 is actively recruiting participants. Contact the research team at samuli.aspinen@hus.fi for enrollment information.

Where is the NCT04260165 trial being conducted?

This trial is being conducted at Helsinki, Finland, Jyväskylä, Finland, Kotka, Finland, Tampere, Finland and 1 additional location.

Who is sponsoring the NCT04260165 clinical trial?

NCT04260165 is sponsored by Töölö Hospital. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology